Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhang Xu

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Current Topics in Medicinal Chemistry|February 4, 2006
Control of chronic inflammation with pathway selective estrogen receptor ligandsRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Virologica Sinica|December 14, 2011
Genetic characteristics of 2009 pandemic H1N1 influenza a viruses isolated from Mainland ChinaJiu-Ru Zhao, Yong-Dong Li, Li-Min Pan, et al.
Acta Pharmacologica Sinica|July 23, 2020
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathwaysMiao Yu, Zhi-Xiao Fang, Wei-Wei Wang, et al.
The American Journal of Pathology|October 15, 2022
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated HepatitisJosepmaria Argemi, Komal Kedia, Marina A Gritsenko, et al.
JCI Insight|February 22, 2023
Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodiesDa-Wei Chen, Tian Kang, Xiu-Zhang Xu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2025
Proinflammatory macrophages release CXCL5 to regulate T cell function and limit effects of αPD-1 in steatosis-driven liver cancerTaojian Tu, Handan Hong, Diala Alhousari, et al.
Nature Communications|January 5, 2021
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemiaHu Lei, Han-Zhang Xu, Hui-Zhuang Shan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translationZhang Xu, Jung-Hyun Choi, David L Dai, et al.
JAMA Network Open|March 11, 2026
Sivelestat and Incidence of Acute Respiratory Distress Syndrome After Cardiovascular Surgery: A Randomized Clinical TrialTuo Pan, Can Xu, Ya-Peng Wang, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Current Topics in Medicinal Chemistry|February 4, 2006
Control of chronic inflammation with pathway selective estrogen receptor ligandsRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Virologica Sinica|December 14, 2011
Genetic characteristics of 2009 pandemic H1N1 influenza a viruses isolated from Mainland ChinaJiu-Ru Zhao, Yong-Dong Li, Li-Min Pan, et al.
Acta Pharmacologica Sinica|July 23, 2020
Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathwaysMiao Yu, Zhi-Xiao Fang, Wei-Wei Wang, et al.
The American Journal of Pathology|October 15, 2022
Integrated Transcriptomic and Proteomic Analysis Identifies Plasma Biomarkers of Hepatocellular Failure in Alcohol-Associated HepatitisJosepmaria Argemi, Komal Kedia, Marina A Gritsenko, et al.
JCI Insight|February 22, 2023
Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodiesDa-Wei Chen, Tian Kang, Xiu-Zhang Xu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 26, 2007
[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]Ji-dong Jia, Jin-lin Hou, You-kuan Yin, et al.
JHEP Reports : Innovation in Hepatology|June 11, 2025
Proinflammatory macrophages release CXCL5 to regulate T cell function and limit effects of αPD-1 in steatosis-driven liver cancerTaojian Tu, Handan Hong, Diala Alhousari, et al.
Nature Communications|January 5, 2021
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemiaHu Lei, Han-Zhang Xu, Hui-Zhuang Shan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2022
SARS-CoV-2 impairs interferon production via NSP2-induced repression of mRNA translationZhang Xu, Jung-Hyun Choi, David L Dai, et al.
JAMA Network Open|March 11, 2026
Sivelestat and Incidence of Acute Respiratory Distress Syndrome After Cardiovascular Surgery: A Randomized Clinical TrialTuo Pan, Can Xu, Ya-Peng Wang, et al.
Pageof 18